Health
First Randomized Trial Reassures on ACEIs, ARBs in COVID-19 – Medscape
The BRACE CORONA study found no difference in key outcomes between patients continuing vs stopping their medication.
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
The first randomized study to compare continuing vs stopping angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) for patients with COVID-19 has shown no difference in key outcomes between the two approaches.
The BRACE CORONA trial conducted in patients had been taking an ACE inhibitor or an ARB on a long-term basis and who were subsequently hospitalized with C…
-
General22 hours agoWondering about winter | The Spectator Australia
-
General21 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
Noosa News21 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
General21 hours agoNo ‘band-aid solution’: sweating coal risky business